The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B

BACKGROUND AND OBJECTIVES: Pegylated interferon alpha-2a (peg-IFN α-2a) and entecavir (ETV) are both recommended as the first-line antiviral drugs for chronic hepatitis B (CHB) at present. We aimed to compare the efficacy and safety between peg-IFN α-2a and ETV initial therapy in children and adoles...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yi, Zhou, Yingzhi, Wang, Huimin, Peng, Xiaorong, Chang, Yunan, Hu, Peng, Ren, Hong, Xu, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297582/
https://www.ncbi.nlm.nih.gov/pubmed/35854256
http://dx.doi.org/10.1186/s12887-022-03482-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297582/
https://www.ncbi.nlm.nih.gov/pubmed/35854256
http://dx.doi.org/10.1186/s12887-022-03482-0

Ejemplares similares